Type 2 diebetes. Diabetes mellitus due to underlying condition
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes (fasting blood sugar less than or equal to 126 Milligrams in deciliter and two-hour blood sugar greater than or equal to 200 Milligrams in deciliter) Receiving blood sugar lowering drugs HbA1c more than 10% Body mass index less than 40 kilogram in square meter
Exclusion criteria
Exclusion criteria: Insulin or liraglutide injection Type 1 diabetes History of chronic liver and kidney disease, diabetic foot ulcer, various malignancies, rheumatic and infectious diseases • Take any herbal medicine or herbal medicine to control blood sugar at present History of any allergies to herbs Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1c. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: En Chromatography.;Weight. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Scales.;Total cholesterol. Timepoint: Baseline, after 8 weeks of the intervention (At the end of the intervention). Method of measurement: Autoanalyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences